FDA
approval
· 2019-08-22
FDA Approved: FULVESTRANT — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
Summary
The FDA approved Glenmark Pharmaceuticals' generic fulvestrant for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women v…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for FULVESTRANT (FULVESTRANT)